Dear Sir, I read the article by Bagcioglu et al. with great interest [1] . This is one of the first and most valuable studies in literature that compares the cost-effectiveness of micropercutaneous nephrolithotomy (microperc) and retrograde intrarenal surgery (RIRS). Working on cost-effect studies is quite difficult because they have multiple variables. Thank you to the authors for presenting this study with a clear and brief expression.
However, there seems to be a methodological mistake while calculating the costs of reusable materials per case. Disposable materials are a variable that can be taken into account on a case-by-case basis [2] , but reusable materials can be used for several cases depending on their life span. For this reason, reusable materials should be calculated in a different manner. For example, the cost of a laser per case cannot be calculated by dividing the overall cost of the laser device into 309 cases because the life span of a typical laser is much more longer. Based on our experiences, a laser device can be used for more than a thousand cases. Similarly, during the calculation of the cost per case for microperc and RIRS, consideration needs to be placed on the life span of devices used in microperc and RIRS. According to our experience, we estimate that a microperc can be used for more than 63 cases and RIRS can be used for more than 48 cases. This analysis cannot give us an exact cost of the devices per each case as the fragility and life span of microperc and RIRS varies a lot among each 
